UK biotech developing gene therapies for rare retinal diseases.
Industry: Health Care
First Day Return: +71.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/31/2017 |
Offer Price | $14.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/27/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | London, United Kingdom |
Founded | 2013 |
Employees at IPO | 23 |
Website www.nightstartx.com |